ZIM
ASMB icon

Zacks Investment Management’s Assembly Biosciences ASMB Stock Holding History

Zacks Investment Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,544
Closed -$250K – 518
2019
Q2 		$250K Sell
1,544
-916
-37% -$174K 0.01% 496
2019
Q1 		$581K Buy
+2,460
New +$623K 0.01% 446
2018
Q2 		– Sell
-2,977
Closed -$1.75M – 548
2018
Q1 		$1.75M Sell
2,977
-3,020
-50% -$1.87M 0.04% 293
2017
Q4 		$3.26M Buy
+5,997
New +$2.71M 0.07% 188

Other funds holding ASMB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Zacks Investment Management's ASMB Position: Q3 2019 in Review

Zacks Investment Management sold out of Assembly Biosciences (ASMB) in Q3 2019, closing a stake of 1,544 shares — an estimated $250K sold.

Zacks Investment Management first reported a position in ASMB in Q4 2017 and held it in 4 quarters. The position peaked at $3.26M in Q4 2017. 98 funds tracked by Wall St. Rank hold ASMB as of Q3 2019.

  • Zacks Investment Management reported no remaining Assembly Biosciences position as of Q3 2019 after selling out during the quarter.
  • Zacks Investment Management sold 1,544 Assembly Biosciences shares in Q3 2019, an estimated $250K.
  • Zacks Investment Management first reported a position in Assembly Biosciences in Q4 2017 and held it in 4 quarters.
  • Zacks Investment Management's Assembly Biosciences position peaked at $3.26M in Q4 2017.
  • 98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2019.

Based on Zacks Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.